Literature DB >> 2955522

Hematoma of the rectus abdominis muscle: a complication of subcutaneous heparin therapy.

K B Webb, S Hadzima.   

Abstract

We have reported a case of hematoma of the rectus abdominis muscle resulting from prophylactic subcutaneous heparin therapy. The resultant right lower quadrant pain mimicked acute appendicitis. Because the use of prophylactic heparin is so prevalent in the hospital, it is important to be aware of this potential complication, which may be preventable by proper injection technique.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2955522     DOI: 10.1097/00007611-198707000-00026

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  5 in total

1.  Hemomediastinum induced by heparinization after stellate ganglion blockada.

Authors:  H Noda; S Kato; T Miyazaki
Journal:  J Anesth       Date:  1992-07       Impact factor: 2.078

2.  Abdominal wall haematoma in cardioembolic stroke due to enoxaparine therapy: a report of two cases.

Authors:  Erhan Turkoglu; Hayat Guven; Bora Gurer; Selim Selcuk Comoglu
Journal:  BMJ Case Rep       Date:  2009-06-15

3.  Drug use problems with self-injected low-molecular-weight heparins in primary care.

Authors:  Seraina Mengiardi; Dimitrios A Tsakiris; Markus L Lampert; Kurt E Hersberger
Journal:  Eur J Clin Pharmacol       Date:  2010-11-24       Impact factor: 2.953

4.  Rectus Sheath Hematoma in COVID-19 Patients as a Mortal Complication: A Retrospective Report.

Authors:  Hossein Zabihi Mahmoudabadi; Azar Hadadi; Mohammad Reza Fattahi; Samira Kafan; Mohammad Ashouri; Rashad Allahbeigi; Reza Hajebi
Journal:  Int J Clin Pract       Date:  2022-02-12       Impact factor: 3.149

Review 5.  Spontaneous rectus sheath hematoma presenting with acute abdominal pain: a case series and review of the literature.

Authors:  Dogac Niyazi Ozucelik; Yucel Neslihan; Mucahit Emet; Selcuk Coskun
Journal:  Ann Saudi Med       Date:  2005 May-Jun       Impact factor: 1.526

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.